Cargando…
Evaluation of Ga-DOTA-(D-Asp)(n) as bone imaging agents: D-aspartic acid peptides as carriers to bone
(67)Ga-DOTA-(L-Asp)(11) and (67)Ga-DOTA-(L-Asp)(14), which have been developed as bone imaging agents, showed a high accumulation in bone and a rapid blood clearance in mice. However, peptides composed of D-amino acids are more stable in vivo than those composed of their L-equivalents. In this study...
Autores principales: | Ogawa, Kazuma, Ishizaki, Atsushi, Takai, Kenichiro, Kitamura, Yoji, Makino, Akira, Kozaka, Takashi, Kiyono, Yasushi, Shiba, Kazuhiro, Odani, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656653/ https://www.ncbi.nlm.nih.gov/pubmed/29070853 http://dx.doi.org/10.1038/s41598-017-14149-7 |
Ejemplares similares
-
Development of Novel Radiogallium-Labeled Bone Imaging Agents Using Oligo-Aspartic Acid Peptides as Carriers
por: Ogawa, Kazuma, et al.
Publicado: (2013) -
Development and evaluation of a novel radioiodinated vesamicol analog as a sigma receptor imaging agent
por: Ogawa, Kazuma, et al.
Publicado: (2012) -
Radiobrominated benzimidazole-quinoline derivatives as Platelet-derived growth factor receptor beta (PDGFRβ) imaging probes
por: Effendi, Nurmaya, et al.
Publicado: (2018) -
Evaluation of Chlorella as a Decorporation Agent to Enhance the Elimination of Radioactive Strontium from Body
por: Ogawa, Kazuma, et al.
Publicado: (2016) -
Decreasing undesirable absorbed radiation to the intestine after administration of radium-223 dichloride for treatment of bone metastases
por: Ogawa, Kazuma, et al.
Publicado: (2020)